Starpharma lifts Petalion stake to 66%, gaining majority control
Starpharma Holdings raised its equity interest in Petalion to 66%, securing majority ownership. It will contribute up to AUD 5.0 million, including AUD 3.0 million in cash.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Starpharma Holdings said it has increased its equity interest in Petalion to 66%, which gives it majority ownership. The company will contribute up to AUD 5.0 million to Petalion, including AUD 3.0 million in cash. Petalion will also become a UK-incorporated subsidiary of Starpharma.
why it matters
The deal is small and concerns a single biotech company, so its effect on broader markets should be limited. For Starpharma shareholders, it marks a move to full control of Petalion and a restructuring under a UK holding entity.
tags
instruments
sources
- Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership — Reuters, 20 October 2026 at 01:02 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗